Daily Life and Long-Term Health with MADD
At a Glance
For people with multiple acyl-CoA dehydrogenase deficiency (MADD), long-term health depends on an individualized sick-day plan, regular monitoring of muscle, liver, heart, and glucose health, and support for emotional and social challenges.
Managing Multiple acyl-CoA dehydrogenase deficiency (MADD) is a marathon, not a sprint. While the initial focus is often on preventing immediate crises, long-term health requires a proactive approach to monitoring organ systems and balancing the benefits of treatment with potential side effects [1][2].
Living with MADD means becoming an expert in your own body (or your child’s). Because the condition is so variable, your metabolic team will customize a management plan that evolves as you grow and age [3].
Home Management of Mild Illnesses
Not every sniffle requires a trip to the ER, but every illness in a person with MADD must be taken seriously. The goal of “sick-day” management at home is to provide enough carbohydrates to stop the body from burning its own fat and protein [4][5].
You should have a specific, fill-in Sick Day Plan provided by your metabolic team. This plan should include:
- Specific Fluids: The exact carbohydrate-rich medical fluid or formula to use. (Do not rely on plain water or improvise a sugary drink unless your team has approved it.)
- Amounts and Frequency: How much fluid to consume and how often.
- The “ER Threshold”: You must move from home care to the hospital if you experience vomiting (unable to keep fluids down), lethargy, confusion, or if you cannot maintain the prescribed intake in your sick-day plan [6][7]. These are signs that IV glucose is urgently needed [8].
Long-Term Monitoring: Protecting Your Organs
Because MADD affects energy production, several organ systems require check-ups. The necessity and frequency of these tests depend entirely on your specific phenotype, symptoms, and age.
1. Muscle Health and Strength
Muscle weakness and exercise intolerance are common, especially in late-onset MADD [9][10]. Your team may monitor:
- Creatine Kinase (CK): A blood marker for muscle damage.
- Physical Strength: Routine exams to check for changes in muscle tone or endurance [9]. Talk to your team about safe exercise practices, as strenuous activity can be a trigger for some.
2. Liver and Heart Health
The liver and heart are highly dependent on efficient energy use. Depending on your clinical baseline, your doctor may recommend:
- Liver Monitoring: MADD can occasionally cause hepatic steatosis (fatty liver) [11]. Routine blood tests (like liver enzymes) and occasional ultrasounds may be indicated [12].
- Cardiac Screening: Some people with fatty-acid oxidation disorders develop cardiomyopathy [13]. Your specialist may refer you to a cardiologist for echocardiograms or ECGs if your phenotype or symptoms suggest a risk [13][3].
Balancing the Diet: Long-Term Risks
The high-carbohydrate diet used to treat MADD is life-saving, but it is important to monitor overall health.
- Diabetes Risk: While a high-carbohydrate diet is necessary, it brings a potential long-term risk of insulin resistance or Type 2 diabetes, though this is not a certainty [4]. Your doctor will monitor your glucose and HbA1c based on ordinary clinical risk factors and your specific dietary plan [4].
The Psychological Weight of MADD
Living with a rare, life-threatening metabolic disorder takes a significant emotional toll. “Metabolic anxiety”—the constant fear of a crisis triggered by a simple cold or a missed meal—is a real and valid experience for patients and caregivers alike [14].
The strict dietary requirements can also lead to social isolation or stress during holidays and school events [15]. It is highly recommended to include a psychologist or social worker as part of your care team to help navigate the mental health challenges of living with a rare disorder. Connecting with rare-disease support groups can also provide a community of people who understand the unique pressures of the MADD lifestyle.
Common questions in this guide
What should I do when I have a mild illness with MADD?
Which symptoms mean home sick-day care is no longer safe for someone with MADD?
What monitoring does long-term MADD care usually involve?
Why might someone with MADD need liver or heart tests?
Can the high-carbohydrate MADD diet increase diabetes risk?
How can families cope with the emotional and social stress of MADD?
Questions For You
Answer a question to get research tailored to you. Your answers are private.
Get notified when new evidence is published on Multiple acyl-CoA dehydrogenase deficiency.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Which specific labs (like CK or liver enzymes) do you want to monitor most frequently for me/my child based on our phenotype?
- 2.Based on my/my child's history, do we need routine echocardiograms or ECGs to check for cardiomyopathy?
- 3.Can you provide a fill-in 'Sick Day Plan' that details exact carbohydrate fluids and amounts for home care?
- 4.At what point do my normal risk factors warrant screening for insulin resistance or checking HbA1c levels?
- 5.Can you refer us to a psychologist or social worker who has experience with the burden of chronic metabolic conditions?
References
References (15)
- 1
[Consensus on screening, diagnosis and treatment of multiple acyl-CoA dehydrogenase deficiency].
Division Of Genetics And Metabolomics Child Diseases And Health Care Branch Chinese Association For Maternal And Child Health , Chen X, Sun Y, et al.
Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2021; (38(5)):414-418 doi:10.3760/cma.j.cn511374-20200829-00630.
PMID: 33974246 - 2
Management of Multiple Acyl-CoA Dehydrogenase Deficiency (MADD) in Pregnancy.
Shear MA, LaTray A, Chang IJ, et al.
Metabolites 2025; (15(7)) doi:10.3390/metabo15070432.
PMID: 40710532 - 3
Late-onset multiple acyl-CoA dehydrogenase deficiency: an insidious presentation.
Rao NN, Burns K, Manolikos C, Hodge S
BMJ case reports 2023; (16(5)) doi:10.1136/bcr-2022-252668.
PMID: 37217231 - 4
Stealthy progression of type 2 diabetes mellitus due to impaired ketone production in an adult patient with multiple acyl-CoA dehydrogenase deficiency.
Ikeda N, Wada Y, Izumi T, et al.
Molecular genetics and metabolism reports 2024; (38()):101061 doi:10.1016/j.ymgmr.2024.101061.
PMID: 38469101 - 5
A case report of a mild form of multiple acyl-CoA dehydrogenase deficiency due to compound heterozygous mutations in the ETFA gene.
Chautard R, Laroche-Raynaud C, Lia AS, et al.
BMC medical genomics 2020; (13(1)):12 doi:10.1186/s12920-020-0665-6.
PMID: 31996215 - 6
Glutaric acidemia type 2 presenting as a surgical acute abdomen: a case of unnecessary exploratory laparotomy in an adult.
Bilal PK, Erkoç SK, Polat B, et al.
Archive of clinical cases 2026; (13(3)):108-111 doi:10.22551/2026.52.1303.10350.
PMID: 42751163 - 7
Late-Onset Multiple Acyl-CoA Dehydrogenase Deficiency Presenting as Hyperammonemia and Encephalopathy: Case Series.
Viguera Altolaguirre C, Stergachis AB, Sweetser DA, Gold NB
The Neurohospitalist 2025; (15(4)):372-376 doi:10.1177/19418744251324959.
PMID: 40051723 - 8
Myogenic Disease and Metabolic Acidosis: Consider Multiple Acyl-Coenzyme A Dehydrogenase Deficiency.
Dernoncourt A, Bouchereau J, Acquaviva-Bourdain C, et al.
Case reports in critical care 2019; (2019()):1598213 doi:10.1155/2019/1598213.
PMID: 31934457 - 9
Diagnostic Challenges in Late Onset Multiple Acyl-CoA Dehydrogenase Deficiency: Clinical, Morphological, and Genetic Aspects.
Lupica A, Oteri R, Volta S, et al.
Frontiers in neurology 2022; (13()):815523 doi:10.3389/fneur.2022.815523.
PMID: 35309592 - 10
Multiple acyl-CoA dehydrogenase deficiency (MADD) as a cause of late-onset treatable metabolic disease.
Béhin A, Acquaviva-Bourdain C, Souvannanorath S, et al.
Revue neurologique 2016; (172(3)):231-41.
PMID: 27038534 - 11
Hepatic Presentation of Late-Onset Multiple Acyl-CoA Dehydrogenase Deficiency (MADD): Case Report and Systematic Review.
Siano MA, Mandato C, Nazzaro L, et al.
Frontiers in pediatrics 2021; (9()):672004 doi:10.3389/fped.2021.672004.
PMID: 34041209 - 12
Late-onset MADD: a rare cause of cirrhosis and acute liver failure?
Soldath P, Lund A, Vissing J
Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology 2020; (39(1)):19-23 doi:10.36185/2532-1900-003.
PMID: 32607475 - 13
Cardiologic evaluation of Turkish mitochondrial fatty acid oxidation disorders.
Balci MC, Karaca M, Ergul Y, et al.
Pediatrics international : official journal of the Japan Pediatric Society 2022; (64(1)):e15317 doi:10.1111/ped.15317.
PMID: 36331231 - 14
Determinants of Riboflavin Responsiveness in Multiple Acyl-CoA Dehydrogenase Deficiency.
Yıldız Y, Talim B, Haliloglu G, et al.
Pediatric neurology 2019; (99()):69-75 doi:10.1016/j.pediatrneurol.2019.06.015.
PMID: 31331668 - 15
Late-Onset Multiple Acyl-CoA Dehydrogenase Deficiency (MADD): A Case Report With a Complex Biochemical Profile.
Penicaud R, Ferron JB, Valette X, et al.
JIMD reports 2025; (66(4)):e70035 doi:10.1002/jmd2.70035.
PMID: 40688386
This page is for informational purposes only and does not constitute medical advice about MADD. Your metabolic team should provide your individualized sick-day plan and decide which monitoring and emergency steps are right for you or your child.